DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tes... read more

DiaSorin Showcases Latest Assays and Reagents for In-Vitro Diagnostics

By LabMedica International staff writers
Posted on 22 May 2023

Image: LIAISON XS delivers a high technology solution for immunochemistry tests (Photo courtesy of DiaSorin)

DiaSorin S.p.A. (‎Saluggia‎, Italy) is exhibiting its range of advanced diagnostic solutions at this year's WorldLab-EuroMedLab that are designed to help clinicians in the management of emergency patients.

At EuroMedLab Rome 2023, DiaSorin is presenting its industry-leading offering of fully-automated chemiluminescent immunoassay (CLIA) panels, designed specifically for diagnosing infectious diseases. The highlight of the event, however, is the LIAISON MeMed BV test - DiaSorin's groundbreaking solution for rapidly and accurately distinguishing between bacterial and viral infections. The LIAISON MeMed BV test is the first of its kind, a fully automated solution that uses data based on the host's response. This innovative test aids physicians in accurately distinguishing between bacterial and viral infections, thereby facilitating quicker, more informed decisions regarding treatment and patient management. Moreover, compared to conventional growth-based microbiology methods, this test enhances lab operational efficiency by saving time and reducing labor through its fully automated and high-throughput approach.

In addition, DiaSorin is highlighting the capabilities of its LIAISON XS analyzer - a high-tech solution for immunochemistry tests. The analyzer enables laboratories to boost both efficiency and clinical effectiveness for routine and specialty testing. Also on display at the event is the LIAISON XL, a fully automated chemiluminescence analyzer, designed to carry out complete sample processing (including sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.), measurement, and evaluation. The LIAISON XL, with its innovative features such as a fully automated solution, superior result quality, flexible configuration, and high efficiency, has the potential to significantly improve the productivity of immunoassay labs.

Related Links:
DiaSorin S.p.A.